1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Denmark >
  5. Bukwang Pharmaceutical Acquires Contera Pharma ApS

M&A Deal Summary

Bukwang Pharmaceutical Acquires Contera Pharma ApS

On November 28, 2014, Bukwang Pharmaceutical acquired life science company Contera Pharma ApS

Acquisition Highlights
  • This is Bukwang Pharmaceutical’s 1st transaction in the Life Science sector.
  • This is Bukwang Pharmaceutical’s 1st transaction in Denmark.

M&A Deal Summary
Date 2014-11-28
Target Contera Pharma ApS
Sector Life Science
Buyer(s) Bukwang Pharmaceutical
Deal Type Add-on Acquisition

Target

Contera Pharma ApS

Copenhagen, Denmark
Contera Pharma ApS is involved in identifying and developing treatments for patients suffering from movement disorders.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Bukwang Pharmaceutical

Seoul, South Korea
Category Company
Founded 1960
Sector Life Science
Employees606
Revenue 160.1B KRW (2024)
DESCRIPTION

Bukwang Pharmaceutical is a developer, manufacturer, and distributor of pharmaceutical products including therapeutics, prescription drugs, over-the-counter drugs, personal hygiene amenities and health supplements under "Vitamin Republic" brand name. The company specializes in Gastrointestinal, CNS, and Metabolic pharmaceutical products. Bukwang Pharmaceutical was founded in 1960 and is based in Seoul, South Korea.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Denmark M&A 1 of 1
Year: 2014 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal